Gilead Sciences Inc. (GILD)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

333 LAKESIDE DR FOSTER CITY, CA 94404

Gilead Sciences is a biopharmaceutical company. Co.'s product portfolio includes Truvada, Atripla, Viread and Emtriva for the treatment of human immunodeficiency virus infection; Hepsera and Viread for the treatment of hepatitis B; AmBisome for the treatment of fungal infections; Letairis for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of angina; Vistide for the treatment of cytomegalovirus retinitis; and Cayston for cystic fibrosis patients with Pseudomonas aeruginosa. Co. owns or have rights to a range of trademarks, copyrights and trade names, such as, among others, GILEAD, GILEAD SCIENCES, TRUVADA, VIREAD, and HEPSERA.

Data as of 2020-06-06
Market Cap96.273 Billion Shares Outstanding1.254 Billion Avg 30-day Volume17.264 Million
P/E Ratio19.9 Dividend Yield3.544 EPS3.89
Price/Sales4.238 Price cash flow ratio11.0 Price free cash flow ratio29.3
Book Value17.59 Price to Tangible Book21.87 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.184459
BETA0.68444 52-week High/Low85.97 / 60.89 Stddev0.06841
View SEC Filings from GILD instead.

View recent insider trading info

Funds Holding GILD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GILD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

35.1 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

45.7 Thousand total shares from 12 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MEYERS JAMES R

  • Director
0 2020-05-28 0

ALTON GREGG H

  • Director
0 2020-05-27 0

WASHINGTON ROBIN L

  • Director
33,643 2020-05-22 0

CARTER PAUL RUTHERFORD

  • Director
20,320 2020-05-13 0

KRAMER KELLY A. EVP AND CFO

  • Officer
276,932 2020-05-10 1

BARTON JACQUELINE K

  • Director
0 2020-05-06 1

HORNING SANDRA

  • Director
0 2020-05-06 3

LOFTON KEVIN E

  • Director
88,849 2020-05-05 9

WOLD OLSEN PER

  • Director
100,124 2020-05-05 3

WILSON GAYLE E

  • Director
129,052 2020-05-05 2

WHITLEY RICHARD JAMES

  • Director
29,688 2020-05-05 5

MANWANI HARISH

  • Director
3,718 2020-05-05 1

PLETCHER BRETT A EVP,CORP AFFAIRS & GEN COUNSEL

  • Officer
14,644 2020-05-05 17

COGAN JOHN FRANCIS

  • Director
54,860 2020-05-04 9

WILFONG DIANE E. SVP, CONTROLLER & CAO

  • Officer
11,421 2020-05-04 5

MCHUTCHISON JOHN G CEO AND PRESIDENT

  • Officer
  • Director
150,000 2020-03-27 0

O'DAY DANIEL PATRICK CHAIRMAN & CEO

  • Officer
  • Director
0 2020-03-10 3

MERCIER JOHANNA CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-03-10 3

DICKINSON ANDREW D EVP, CHIEF FINANCIAL OFFICER

  • Officer
11,400 2020-03-10 5

PARSEY MERDAD CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-10 3

MARTIN JOHN C

  • Director
5,187 2020-02-28 0

HAMILL LAURA

  • Director
0 2020-02-12 0

LANGE LOUIS G

  • Director
0 2020-01-15 0

BISCHOFBERGER NORBERT W

  • Director
0 2019-06-26 0

YOUNG KEVIN

  • Director
30,000 2019-05-13 0

MILLIGAN JOHN F PRESIDENT AND CEO

  • Officer
  • Director
1,574,306 2018-11-27 0

MOORE NICHOLAS G

  • Director
0 2018-03-29 0

MADIGAN JOHN W

  • Director
18,548 2017-05-09 0

DAVIGNON ETIENNE

  • Director
838,652 2016-05-06 0

HILLS CARLA A

  • Director
39,285 2016-05-06 0

DENNY JAMES M

  • Director
281,158 2012-11-28 0

METZA KRISTEN SVP, HUMAN RESOURCES

  • Officer
No longer subject to file 2012-11-01 0

MOORE GORDON EARLE

  • Director
1,063,839 2012-08-14 0

BERG PAUL

  • Director
No longer subject to file 2011-05-11 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BARTON JACQUELINE K - Director

2020-05-06 A 1,936 a 6,489 0.00 direct

HORNING SANDRA - Director

2020-05-06 A 7,886 a 7,886 0.00 direct

MANWANI HARISH - Director

2020-05-06 A 1,936 a 1,936 3,718.00 direct

WOLD OLSEN PER - Director

2020-05-06 A 1,936 a 1,936 100,124.00 direct

WHITLEY RICHARD JAMES - Director

2020-05-06 A 7,886 a 7,886 29,688.00 direct

KRAMER KELLY A. - Director

2020-05-06 A 7,886 a 7,886 0.00 direct

HORNING SANDRA - Director

2020-05-06 A 1,936 a 2,568 0.00 direct

LOFTON KEVIN E - Director

2020-05-06 A 7,886 a 7,886 88,849.00 direct

WHITLEY RICHARD JAMES - Director

2020-05-06 A 1,936 a 5,964 29,688.00 direct

BARTON JACQUELINE K - Director

2020-05-06 A 7,886 a 7,886 0.00 direct

KRAMER KELLY A. - Director

2020-05-06 A 1,936 a 8,730 0.00 direct

MANWANI HARISH - Director

2020-05-06 A 7,886 a 7,886 3,718.00 direct

LOFTON KEVIN E - Director

2020-05-06 A 1,936 a 9,830 88,849.00 direct

WOLD OLSEN PER - Director

2020-05-06 A 7,886 a 7,886 100,124.00 direct

WOLD OLSEN PER - Director

2020-05-05 M 2,270 a 100,124 100,124.00 direct

WHITLEY RICHARD JAMES - Director

2020-05-05 M 2,270 d 4,028 29,688.00 direct

WILSON GAYLE E - Director

2020-05-05 M 2,270 a 129,052 129,052.00 direct

PLETCHER BRETT A - Officer EVP,CORP AFFAIRS & GEN COUNSEL

2020-05-05 S 13,210 $79.23 d 14,644 14,644.00 direct

MANWANI HARISH - Director

2020-05-05 M 2,270 a 4,137 3,718.00 direct

LOFTON KEVIN E - Director

2020-05-05 M 2,270 d 7,894 88,849.00 direct

WHITLEY RICHARD JAMES - Director

2020-05-05 M 2,270 a 29,688 29,688.00 direct

PLETCHER BRETT A - Officer EVP,CORP AFFAIRS & GEN COUNSEL

2020-05-05 M 650 d 0 14,644.00 direct

PLETCHER BRETT A - Officer EVP,CORP AFFAIRS & GEN COUNSEL

2020-05-05 M 650 $24.30 a 27,854 14,644.00 direct

MANWANI HARISH - Director

2020-05-05 M 2,270 d 0 3,718.00 direct

LOFTON KEVIN E - Director

2020-05-05 M 2,270 a 88,849 88,849.00 direct

WOLD OLSEN PER - Director

2020-05-05 M 2,270 d 0 100,124.00 direct

WILSON GAYLE E - Director

2020-05-05 M 2,270 d 0 129,052.00 direct

PLETCHER BRETT A - Officer EVP,CORP AFFAIRS & GEN COUNSEL

2020-05-05 M 12,560 d 0 14,644.00 direct

PLETCHER BRETT A - Officer EVP,CORP AFFAIRS & GEN COUNSEL

2020-05-05 M 12,560 $40.56 a 27,204 14,644.00 direct

MANWANI HARISH - Director

2020-05-05 F 419 $79.14 d 3,718 3,718.00 direct

WILFONG DIANE E. - Officer SVP, CONTROLLER & CAO

2020-05-04 M 11,486 d 3,829 11,421.00 direct

COGAN JOHN FRANCIS - Director

2020-05-04 M 2,416 d 0 54,860.00 direct yes

WILFONG DIANE E. - Officer SVP, CONTROLLER & CAO

2020-05-04 S 12,264 $80.09 d 11,421 11,421.00 direct

COGAN JOHN FRANCIS - Director

2020-05-04 S 2,416 $81.75 d 54,860 54,860.00 direct

WILFONG DIANE E. - Officer SVP, CONTROLLER & CAO

2020-05-04 M 11,486 $66.36 a 23,685 11,421.00 direct

COGAN JOHN FRANCIS - Director

2020-05-04 M 2,416 $19.63 a 57,276 54,860.00 direct yes

COGAN JOHN FRANCIS - Director

2020-04-27 M 2,413 d 2,416 54,860.00 direct yes

COGAN JOHN FRANCIS - Director

2020-04-27 S 2,413 $79.90 d 54,860 54,860.00 direct

COGAN JOHN FRANCIS - Director

2020-04-27 M 2,413 $19.63 a 57,273 54,860.00 direct yes

COGAN JOHN FRANCIS - Director

2020-04-20 M 2,413 d 4,829 54,860.00 direct yes

COGAN JOHN FRANCIS - Director

2020-04-20 S 2,413 $83.00 d 54,860 54,860.00 direct

COGAN JOHN FRANCIS - Director

2020-04-20 M 2,413 $19.63 a 57,273 54,860.00 direct yes

COGAN JOHN FRANCIS - Director

2020-04-13 M 2,413 $19.63 a 57,273 54,860.00 direct yes

COGAN JOHN FRANCIS - Director

2020-04-13 M 2,413 d 7,242 54,860.00 direct yes

COGAN JOHN FRANCIS - Director

2020-04-13 S 2,413 $75.90 d 54,860 54,860.00 direct

Elevate your investments